PDE4B and neoplasm: Mechanistically, FTO inhibits phosphodiesterases 4B (PDE4B) and 1C (PDE1C) via demethylase activity via m6A modification, resulting in cAMP accumulation and reduced stemness in OC and tumor initiation (91).